Toripalimab Combined With SBRT for NSCLC
Clinical trial NCT06293690 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06293690
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-15
- Primary completion
- 2025-12-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.